INJECTABLE

THROMBOACT INJ

By UNIQUE MEDICARE

₹ 90

₹ 90 M.R.P:

Tax included. Shipping calculated at checkout.

Pack - 30mL

Expires on or after: Feb, 2027

Best deal on the Internet

Prescription Required

Check Availability

Rapid 3-4 Day Delivery,Tiny Extra Fee!

Pet Safe
Best Quality
Fast Delivery
Secure Payment

View full details

About Product

Thromboact Vet Injection by Provimi Animal Nutrition India Pvt. Ltd. is a potent, prescription-only haemostatic injection formulated to rapidly arrest both internal and external capillary bleeding across a broad range of animal species. Containing Carbazochrome Salicylate as its active ingredient at 10 mg per ml, Thromboact Vet acts as a powerful systemic coagulant that reinforces capillary wall integrity and restores normal haemostasis without interfering with the body's broader coagulation cascade. Whether your canine companion has undergone surgical intervention, sustained traumatic injury, or is experiencing bleeding associated with a systemic disease process, Thromboact Vet provides the veterinarian with a reliable, fast-acting injectable tool to bring haemorrhage under swift and dependable control. Animeal is proud to offer Thromboact Vet Injection as part of its carefully selected range of clinically credible, veterinarian-prescribed emergency and perioperative pharmaceutical solutions for your beloved pet.

Ingredients:

Carbazochrome Salicylate (equivalent to Adrenochrome Monosemicarbazone IP 10 mg per ml): Carbazochrome Salicylate is the sodium salicylate complex of Adrenochrome Monosemicarbazone (Adrenochrome semi-carbazone, an oxidation product of adrenaline), formulated in this soluble complex form to permit reliable intramuscular injection. Its mechanism of haemostatic action operates exclusively at the level of the microvasculature, particularly capillaries and small venules, and does not involve or interfere with the classic coagulation cascade, prothrombin time, fibrinolysis, or platelet count.

Features and Benefits

Precise Capillary-Level Haemostasis Without Sys...

Precise Capillary-Level Haemostasis Without Systemic Coagulation Risk:
Thromboact Vet targets bleeding at its microvascular origin by reinforcing capillary wall integrity and improving platelet adhesiveness specifically at injury sites, without activating the systemic clotting cascade. This makes it uniquely safe in animals where thrombotic risk must be avoided, as the product does not form emboli and produces no changes to prothrombin time, platelet count, or fibrinolytic activity during treatment.

Broad Species Versatility for Multi-Animal Practices and Large Animal Settings:
Thromboact Vet is approved for use across dogs, cats, cattle, horses, sheep, goats, and pigs, making it a single, versatile haemostatic injectable that serves the full spectrum of companion animal and livestock patients. This breadth of species coverage positions it as an essential preparedness product in any mixed veterinary practice or large animal facility where haemorrhagic emergencies can arise across multiple species.

Rapid Onset of Haemostatic Action in Emergency Bleeding Scenarios:
Administered intramuscularly, Carbazochrome Salicylate is absorbed rapidly and reaches effective haemostatic concentrations in target microvascular tissues within a clinically relevant timeframe. This speed of action is critical in acute haemorrhagic presentations, post-surgical bleeding episodes, and obstetric emergencies where every minute of active blood loss compounds the patient's risk of hypovolaemic shock.

Established Safety Profile with No Cardiovascular or Metabolic Disturbances:
Decades of veterinary clinical use have confirmed that Carbazochrome Salicylate produces no local tissue reaction at the injection site, no systemic metabolic disturbances, and no cardiovascular effects on blood pressure or cardiac output. Its safety profile makes it suitable for use in debilitated, post-surgical, or haemodynamically compromised patients who may not tolerate drugs with cardiovascular side effects.

Effective Against a Wide Spectrum of Haemorrhagic Conditions:
From post-surgical capillary ooze to obstetric haemorrhage, haematuria, epistaxis, gastrointestinal bleeding, and pulmonary haemorrhage, Thromboact Vet addresses the full clinical range of microvascular bleeding encountered in veterinary practice. Its mechanism of strengthening the capillary wall is applicable across virtually any tissue type where capillary integrity is compromised.

Usage and Applications

Precise Capillary-Level Haemostasis Without Sys...

Precise Capillary-Level Haemostasis Without Systemic Coagulation Risk:
Thromboact Vet targets bleeding at its microvascular origin by reinforcing capillary wall integrity and improving platelet adhesiveness specifically at injury sites, without activating the systemic clotting cascade. This makes it uniquely safe in animals where thrombotic risk must be avoided, as the product does not form emboli and produces no changes to prothrombin time, platelet count, or fibrinolytic activity during treatment.

Broad Species Versatility for Multi-Animal Practices and Large Animal Settings:
Thromboact Vet is approved for use across dogs, cats, cattle, horses, sheep, goats, and pigs, making it a single, versatile haemostatic injectable that serves the full spectrum of companion animal and livestock patients. This breadth of species coverage positions it as an essential preparedness product in any mixed veterinary practice or large animal facility where haemorrhagic emergencies can arise across multiple species.

Rapid Onset of Haemostatic Action in Emergency Bleeding Scenarios:
Administered intramuscularly, Carbazochrome Salicylate is absorbed rapidly and reaches effective haemostatic concentrations in target microvascular tissues within a clinically relevant timeframe. This speed of action is critical in acute haemorrhagic presentations, post-surgical bleeding episodes, and obstetric emergencies where every minute of active blood loss compounds the patient's risk of hypovolaemic shock.

Established Safety Profile with No Cardiovascular or Metabolic Disturbances:
Decades of veterinary clinical use have confirmed that Carbazochrome Salicylate produces no local tissue reaction at the injection site, no systemic metabolic disturbances, and no cardiovascular effects on blood pressure or cardiac output. Its safety profile makes it suitable for use in debilitated, post-surgical, or haemodynamically compromised patients who may not tolerate drugs with cardiovascular side effects.

Effective Against a Wide Spectrum of Haemorrhagic Conditions:
From post-surgical capillary ooze to obstetric haemorrhage, haematuria, epistaxis, gastrointestinal bleeding, and pulmonary haemorrhage, Thromboact Vet addresses the full clinical range of microvascular bleeding encountered in veterinary practice. Its mechanism of strengthening the capillary wall is applicable across virtually any tissue type where capillary integrity is compromised.

Frequently Asked Questions

Is Thromboact Vet Injection suitable for all dogs and cats?

Thromboact Vet is suitable for dogs and cats of all breeds and ages when prescribed by a veterinarian for the management of capillary and microvascular haemorrhage. It is not intended for home use and must be administered only by a licensed veterinarian in a clinical setting. Animals with known hypersensitivity to salicylate compounds should be assessed carefully before use, and the attending veterinarian will determine suitability based on the patient's full clinical history.

How often is Thromboact Vet Injection administered?

The dosing frequency and duration are determined entirely by the attending veterinarian based on the nature and severity of the haemorrhagic condition. In most clinical situations, treatment for one day is sufficient to achieve haemostatic control. In cases where ongoing capillary bleeding requires sustained management, the veterinarian may prescribe repeat administration for a further two to three days. The product is not intended for long-term or preventive daily use outside of an active haemorrhagic clinical context.

How effective is Thromboact Vet at controlling surgical and traumatic bleeding?

Carbazochrome Salicylate has been used in veterinary and human haemostatic medicine for over four decades and has a well-established clinical record in controlling capillary bleeding during and following surgical procedures, traumatic injuries, and disease-related haemorrhagic conditions. Its mechanism of reinforcing endothelial wall integrity and promoting platelet adhesiveness at injury sites is particularly effective for diffuse capillary ooze that is difficult to address with individual vessel ligation, making it a valued complement to surgical haemostasis in the veterinary operating theatre.

Are there side effects or safety concerns associated with Thromboact Vet?

Thromboact Vet has a well-documented safety profile established over decades of clinical use. It produces no local tissue reaction at the injection site, no systemic metabolic disturbances, and no effects on blood pressure, cardiac rate, or cardiac output. It does not form emboli or alter normal coagulation parameters. In rare cases, animals with pre-existing hypersensitivity to salicylate compounds may exhibit mild reactions, and any unexpected signs following administration should be reported to your veterinarian promptly. As with all injectables, only qualified veterinary personnel should administer the product using aseptic technique.

How can I access Thromboact Vet Injection through Animeal?

Thromboact Vet Injection is available on Animeal as a prescription veterinary product. A valid veterinary prescription is required before purchase can be completed. Visit animeal.in, search for Thromboact Vet, and our team will guide you through the prescription verification process to ensure this product reaches your pet safely and in compliance with Schedule H pharmaceutical regulations. Our customer care team is available to assist with any queries throughout the process.

View All Questions